The Effect of Premedication on Postoperative Pain and Anxiety in Breast Cancer Surgery
- Conditions
- Female Patients Under the Age of 65 Who Will Undergo Breast Cancer Surgery
- Interventions
- Registration Number
- NCT05647642
- Lead Sponsor
- Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
- Brief Summary
In this study, it was investigated whether the premedication drug administered before the surgery had an effect on postoperative pain and anxiety scores in female patients under the age of 65 who will undergo breast cancer surgery.
- Detailed Description
In this study, it was investigated whether the premedication drug administered before the surgery had an effect on postoperative pain and anxiety scores in female patients under the age of 65 who will undergo breast cancer surgery. The STAI-1(State Trait Anxiety İnventory ) form and APAIS (Amsterdam Preoperative Anxiety and İnformation Scale) scale were filled in for all preoperative patients. Afterwards, the patients were treated with either midazolam or dexmedetothymidine, depending on the anesthesiologist's preference. After administration, he was taken to surgery. As intraoperative analgesics, 2 mg/kg tramadol and 15 mg/kg paracetamol were administered to all patients. postoperative recovery time (aldrete 10), 1., 2.,6.,12.,24. VAS score, postoperative nausea-vomiting scale, STAI-1(State Trait Anxiety İnventory ) form, first need time if postoperative analgesic was needed, and 24-hour total analgesic consumption were recorded. It was aimed to examine the effects of different premedications on postoperative pain and anxiety
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- Female
- Target Recruitment
- 80
- ASA 1-2-3
- 18-65 aged
- Female patients
- Under 18 years old and over 65 years old
- Having a history of cerebrovascular disease illiteracy
- Have visual and auditory problems İnability to cooperate with cognitive function test
- Having emergency surgery
- Those who are unable to read, understand and sign the consent form
- Patients deemed unsuitable by the investigator
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description low dose dexmedetothymidine Precedex and dormicum 0.5 mg/kg dexmedetothymidine 10 minute infusion low dose midazolam Precedex and dormicum 0,025 mg/kg Midazolam high dose midazolam Precedex and dormicum 0,05 mg/kg Midazolam high dose dexmedetothymidine Precedex and dormicum 1mg/kg dexmedetothymidine 10 minute infusion
- Primary Outcome Measures
Name Time Method effect of premedication on postoperative pain and anxiety scores November 2022-December 2022
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
AbdurrahmanYAOTRH
🇹🇷Ankara, Turkey